These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26400629)

  • 1. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
    Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome.
    Cunningham AC; Delport S; Cumines W; Busse M; Linden DEJ; Hall J; Owen MJ; van den Bree MBM
    Br J Psychiatry; 2018 Jan; 212(1):27-33. PubMed ID: 29433607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
    Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
    Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep problems and associations with psychopathology and cognition in young people with 22q11.2 deletion syndrome (22q11.2DS).
    Moulding HA; Bartsch U; Hall J; Jones MW; Linden DE; Owen MJ; van den Bree MBM
    Psychol Med; 2020 May; 50(7):1191-1202. PubMed ID: 31144615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications.
    Stephenson DD; Beaton EA; Weems CF; Angkustsiri K; Simon TJ
    Behav Brain Res; 2015 Jan; 276():190-8. PubMed ID: 24906195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
    Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
    Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
    Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy and seizures in young people with 22q11.2 deletion syndrome: Prevalence and links with other neurodevelopmental disorders.
    Eaton CB; Thomas RH; Hamandi K; Payne GC; Kerr MP; Linden DEJ; Owen MJ; Cunningham AC; Bartsch U; Struik SS; van den Bree MBM
    Epilepsia; 2019 May; 60(5):818-829. PubMed ID: 30977115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome).
    Aneja A; Fremont WP; Antshel KM; Faraone SV; AbdulSabur N; Higgins AM; Shprintzen R; Kates WR
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):105-14. PubMed ID: 17343558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental trajectories in 22q11.2 deletion.
    Swillen A; McDonald-McGinn D
    Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):172-81. PubMed ID: 25989227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
    Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
    Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample.
    Caye A; Agnew-Blais J; Arseneault L; Gonçalves H; Kieling C; Langley K; Menezes AMB; Moffitt TE; Passos IC; Rocha TB; Sibley MH; Swanson JM; Thapar A; Wehrmeister F; Rohde LA
    Epidemiol Psychiatr Sci; 2019 May; 29():e37. PubMed ID: 31088588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.